It has been just revealed the fact that insulin resistance can become a silent driver of pancreatic cancer. Check out the latest reports below.
This can drive pancreatic cancer
Pancreatic cancer, the third leading cause of cancer-related deaths in the US, may have a silent killer lurking within the pancreas cells.
This killer inflames and mutates the cells, turning them into cancerous time bombs.
New research has established a link between elevated insulin, which is caused by poor diet and obesity, and the development of pancreatic cancer. Insulin resistance, which is a condition where the body’s cells do not respond effectively to insulin, leads to elevated blood sugar levels and can potentially cause type 2 diabetes.
Insulin resistance, which is commonly associated with obesity and diabetes, has been identified as a known risk factor for pancreatic cancer.
According to new research conducted by the University of British Columbia (UBC) and published in Cell Metabolism, excess insulin can overstimulate the cells in the pancreas that produce digestive juices.
This leads to inflammation, which in turn can cause these cells to become precancerous.
“These findings have the strongest implications for those who know that they are at higher risk for developing pancreatic ductal adenocarcinoma [the most common form], but are applicable to everyone,” study authors and UBC researchers James Johnson and Janel Kopp told The Epoch Times in an emailed statement.
“Our data shows that the higher risk of pancreatic cancer associated with poor diet and obesity may be due to the higher levels of insulin associated with these conditions,” they added.
A recent study suggests that reducing insulin levels through medication, diet, or exercise may help prevent pancreatic cancer.
The study found that the insulin receptor plays a crucial role in regulating the production of digestive enzymes and inflammation in the pancreas.
The researcher highlighted the importance of understanding how this information can be used to reduce the risk of pancreatic cancer in individuals with high insulin levels.
